BetterLife Pharma Inc C.BETR

Alternate Symbol(s): BETRF

Healthcare

BetterLife Pharma Inc. is a biotechnology company. The Company is primarily focused on developing and commercializing two compounds, BETR-001 and BETR-002, to treat neuro-psychiatric and neurological disorders. BETR-001, which is in preclinical and is a non-hallucinogenic and non- controlled lysergic acid diethylamide (LSD) derivative in development and that is unregulated and therefore can be self-administered. Its synthesis patent for BETR-001 eliminates regulatory hurdles and its pending patent, for composition and method of use, covers treatment of major depressive disorder, anxiety disorder and neuropathic pain and other neuro-psychiatric and neurological disorders. BETR-002, which is in preclinical and is based on honokiol, the active anxiolytic ingredient of magnolia bark. Its pending method of use and formulations patent covers treatment of anxiety related disorders including benzodiazepine dependency. It also owns a drug candidate for the treatment of viral infections.

CSE:BETR - Post by User

BetterLife Pharma Inc > BetterLife Pharma (BETR) let’s go.....

<< Previous

Bullboard Posts

Next >>

Comment by goldmikeon Dec 21, 2020 10:13am

108 Views

Post# 32152050

RE:RE:RE:BetterLife Pharma (BETR) let’s go.....

Stock was at $28 two years ago.. little downside with mega upside entree at $1.50 Break out point on 3 year chart should fly to $2.50 from here https://www.stockwatch.com/Chart/Advanced?time=1&symbol=BETR&region=C

<< Previous

Bullboard Posts

Next >>

Paramount Resources signs $3.32 billion asset sale